Ling Shen Selected Research

4-hydroxy-3-methyl-2-butenyl diphosphate

11/2020	Fast-acting γδ T-cell subpopulation and protective immunity against infections.
1/2019	Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates.
1/2009	Tuberculosis-induced variant IL-4 mRNA encodes a cytokine functioning as growth factor for (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-specific Vgamma2Vdelta2 T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ling Shen Research Topics

Disease

29	Infections 12/2022 - 03/2002
18	Neoplasms (Cancer) 05/2022 - 01/2006
17	Tuberculosis (Tuberculoses) 01/2022 - 01/2007
13	Body Weight (Weight, Body) 12/2021 - 07/2004
6	Inflammation (Inflammations) 09/2021 - 11/2006
6	Obesity 01/2018 - 08/2004
6	Schizophrenia (Dementia Praecox) 01/2018 - 12/2006
5	Coinfection 01/2022 - 10/2004
4	Neuroinflammatory Diseases 01/2022 - 07/2019
4	Ischemic Stroke 11/2020 - 07/2019
4	Multiple Sclerosis 04/2017 - 07/2014
3	Necrosis 01/2022 - 05/2009
3	Chronic Hepatitis B 12/2021 - 11/2006
3	Stroke (Strokes) 10/2021 - 07/2019
3	Central Nervous System Diseases (CNS Diseases) 09/2021 - 07/2019
3	Pain (Aches) 01/2021 - 01/2018
3	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2006
3	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2005
3	Acquired Immunodeficiency Syndrome (AIDS) 12/2018 - 12/2004
3	Bipolar Disorder (Manic Depressive Psychosis) 07/2017 - 11/2013
3	Insulin Resistance 01/2016 - 05/2013
3	Retinoblastoma (Glioblastoma, Retinal) 05/2014 - 06/2011
3	Chronic Hepatitis C 04/2013 - 11/2007
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 05/2014
2	Hypersensitivity (Allergy) 04/2022 - 01/2021
2	Diarrhea 01/2022 - 03/2009
2	COVID-19 01/2022 - 12/2021
2	Fistula 01/2022 - 11/2021
2	Carcinosarcoma 01/2019 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 09/2013
2	Genetic Risk Score 04/2017 - 10/2016
2	Poliomyelitis (Polio) 01/2017 - 01/2017
2	Viremia 01/2017 - 07/2013
2	Reinfection 11/2016 - 10/2004
2	Cognitive Dysfunction 09/2016 - 03/2015
2	Lung Neoplasms (Lung Cancer) 09/2015 - 03/2012
2	Sleep Deprivation 03/2015 - 08/2014
2	Hemoglobinopathies 01/2015 - 08/2011
2	Infectious Mononucleosis (Glandular Fever) 09/2014 - 07/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2014 - 07/2013
2	Prostatic Neoplasms (Prostate Cancer) 05/2014 - 01/2010
2	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 09/2013
2	Breakthrough Infections 01/2014 - 05/2012

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 02/2009
9	CytokinesIBA 01/2022 - 01/2008
9	VaccinesIBA 01/2019 - 01/2007
8	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2005
6	apolipoprotein A-IV (apolipoprotein AIV)IBA 10/2014 - 07/2004
6	Messenger RNA (mRNA)IBA 07/2013 - 12/2004
5	Biological ProductsIBA 05/2022 - 01/2018
5	Circular RNAIBA 11/2020 - 07/2019
5	AntigensIBA 01/2017 - 01/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 03/2009
4	Interleukin-2 (IL2)IBA 12/2022 - 05/2009
4	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 05/2009
4	InterferonsIBA 01/2021 - 11/2007
4	Interleukin-4 (Interleukin 4)IBA 01/2020 - 01/2009
4	Appetite Depressants (Anorectics)IBA 01/2018 - 08/2008
4	Antiviral Agents (Antivirals)IBA 01/2017 - 09/2010
3	EnzymesIBA 10/2021 - 09/2011
3	ImmunosorbentsIBA 10/2021 - 09/2011
3	Vitamin D FDA LinkGeneric 01/2021 - 10/2016
3	RNA (Ribonucleic Acid)IBA 11/2020 - 03/2007
3	4-hydroxy-3-methyl-2-butenyl diphosphateIBA 11/2020 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 05/2011
3	Small Interfering RNA (siRNA)IBA 01/2018 - 06/2011
3	HLA-DRB1 Chains (HLA DRB1)IBA 10/2016 - 07/2014
3	AIDS VaccinesIBA 08/2012 - 05/2011
3	Apolipoproteins E (ApoE)IBA 08/2009 - 06/2005
3	Interferon-alpha (Interferon Alfa)IBA 02/2008 - 11/2006
2	Immunoglobulin E (IgE)IBA 04/2022 - 06/2013
2	LipidsIBA 01/2022 - 11/2021
2	Granzymes (Granzyme)IBA 01/2022 - 01/2008
2	PerforinIBA 01/2022 - 08/2012
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2021
2	Chemokine ReceptorsIBA 01/2022 - 01/2022
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 08/2014
2	Peptides (Polypeptides)IBA 12/2021 - 10/2004
2	Interleukin-6 (Interleukin 6)IBA 10/2021 - 08/2014
2	Glial Fibrillary Acidic ProteinIBA 10/2021 - 09/2008
2	Untranslated RNA (Noncoding RNA)IBA 09/2021 - 07/2019
2	Serotonin ReceptorsIBA 01/2021 - 01/2018
2	Interleukin-12 (IL 12)IBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2019
2	Tamoxifen FDA LinkGeneric 01/2019 - 01/2014
2	Monoclonal AntibodiesIBA 01/2018 - 09/2011
2	AntibodiesIBA 01/2018 - 01/2014
2	Immunoglobulin G (IgG)IBA 09/2016 - 12/2006
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2016 - 05/2012
2	Estrogens (Estrogen)FDA Link 01/2016 - 07/2010
2	AMP-Activated Protein KinasesIBA 09/2015 - 05/2013
2	ginsenoside Rb1IBA 09/2015 - 05/2013
2	MelatoninIBA 03/2015 - 08/2014
2	GlobinsIBA 01/2015 - 08/2011
2	N 30IBA 01/2015 - 11/2006
2	Protein Kinase CIBA 11/2014 - 01/2014

Therapy/Procedure

14	Therapeutics 10/2021 - 08/2008
3	Drug Therapy (Chemotherapy) 01/2017 - 09/2013
3	Restorative Proctocolectomy 10/2011 - 03/2009
2	Immunotherapy 12/2022 - 01/2010